Maximum quantity allowed is 999
请选择数量
CAS RN: 220620-09-7 | 产品编码: T3589
Tigecycline
×
![]()
×
| 产品编码 | T3589 |
| 纯度/分析方法 | >98.0%(HPLC) |
| 分子式/分子量 | C__2__9H__3__9N__5O__8 = 585.66 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 冷冻 (<0°C) |
| 应避免的情况 | 加热 |
| 包装和容器 | 100MG-Glass Bottle with Plastic Insert （查看图片）, 500MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 220620-09-7 |
| Reaxys-RN | 8379453 |
| PubChem物质ID | 354335260 |
| Merck Index (14) | 9432 |
| MDL编号 | MFCD00935753 |
技术规格
| Appearance | Light yellow to Brown powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Specific rotation [a]20/D | -189 to -208 deg(C=0.15, methanol) |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 185 °C(dec.) |
| 比旋光度 [α]D | -199° (C=0.15,CH3OH) |
| 水溶性 | 可溶 |
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H318 : Causes serious eye damage. H360 : May damage fertility or the unborn child. H410 : Very toxic to aquatic life with long lasting effects. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P391 : Collect spillage. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. P405 : Store locked up. |
相关法规
| RTECS# | QI7619500 |
运输信息
| UN编号 | UN3077 |
| 类别 | 9 |
| 包装类别 | III |
| HS编码* | 2941.30-000 |
应用
Tigecycline: The First Glycylcycline Antimicrobial Agent with Activity against Multidrug-Resistant Strains
Tigecycline (GAR-936) is the first glycylcycline antimicrobial agent with expanded broad-spectrum activity against both Gram-negative (except for Pseudomonas aeruginosa) and Gram-positive aerobes and anaerobes. Furthermore, the spectrum of activity extends to multidrug-resistant strains of Staphylococcus aureus (MRSA), Streptococcus pneumoniae, vancomycin-resistant enterococci (VRE), and Enterobacteriaceae, including extended-spectrum β-lactamase (ESBL) producing strains. In addition, tigecycline is able to overcome the major resistance mechanisms, ribosomal protection and efflux. Tigecycline inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking entry of aminoacyl-tRNA molecules into the A site of the ribosome. Tigecycline binds to bacterial ribosomes in a novel way that allows it to overcome tetracycline resistance due to ribosomal protection. (The product is for research purpose only.)
References
- In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)
- Functional, biophysical, and structural bases for antibacterial activity of tigecycline
- Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence (a review)
- Tigecycline: an update (a review)
- Quantitation of tigecycline, a novel glycyclcycline, by liquid chromatography
- Simultaneous analysis of antibiotics in biological samples by ultra high performance liquid chromatography-tandem mass spectrometry
参考文献
文章/手册
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。